O
Orpheusbioscience
orpheusbioscience.com
Website unreachable since Oct 22, 2026
This biotechnology company develops novel therapeutics for autoimmune disorders by utilizing protein fusions of cell autoantigens to target and eliminate specific cells. Their technology enables preclinical characterization and the analysis of patient autoantibody responses, facilitating the development of effective treatments for these conditions.
Traction –/10
Manassas, United States · HQ
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This biotechnology company develops novel therapeutics for autoimmune disorders by utilizing protein fusions of cell autoantigens to target and eliminate specific cells. Their technology enables preclinical characterization and the analysis of patient autoantibody responses, facilitating the development of effective treatments for these conditions.